Provisional Agenda
(Subject to change)
All times mentioned refer to British Standard/Summer Time (BST) – London/GMT +1.
World Time Converter: https://www.worldtimebuddy.com
We have tried to group similar talks, but due to the wide geographical locations of our speakers, this may not always have been possible.
Day 1: Wednesday 16th September
1000: Welcome to Oxford on behalf of the conference co-chairs by Professor Anna Nekaris, Professor in Primate Conservation, Oxford Brookes University, Oxford, UK
Painful plants
1010: Professor Irina Vetter, Co-Director, IMB Centre for Pain Research and Principal Research Fellow, Institute for Molecular Bioscience, the University of Queensland, Queensland, Australia
Neurotoxic venom peptides from the giant Australian stinging tree
1030: Symposium on snakebite in Africa, from West to East – Chair Professor David Warrell
1035: GHANA
Dr John Amuasi, Leader, Global Health and Infectious Diseases Research Group, Kumasi Collaborative Center for Research in Tropical Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
Reducing Snakebite Envenoming in Ghana: A low-hanging fruit
1055: NIGERIA
Professor Abdulrazak Habib and Dr Saidu Abubakar Ballah, Infectious Disease Unit, Aminu Kano Teaching Hospital, Bayero University, Kano, Nigeria
Challenges and Prospects of Snake Antivenom Supply in Sub-Saharan Africa
1115: CAMEROON
Dr Frank Tianyi Tianyi, Chief Medical Officer, Mayo Darle Sub Divisional Hospital, Cameroon; and Oxford University Africa Society, UK
Shortcomings in snakebite management in rural Cameroon
1135: KENYA
Dr Mitchel Otieno Okumu, Department of Public Health, Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Nairobi, Nairobi, Kenya
Management and cost of snakebite injuries at a teaching and referral hospital in Western Kenya
1155: Discussion and close of symposium
1155: Dr Tamar Gosh, Royal Society of Tropical Medicine and Hygiene, London, UK
RSTMH small grants and the World Snakebite Awareness Day
1200: Break and Posters-I
Poster flash-talks – Moderator Dr Muhammad Sohail
- Maike Fischer, Germany
- Maria Ikonomopoulou, Spain
- Daniel Jestrzemski, Germany
- David Mélendez Martínez, Mexico
- Esta Saaiman, Namibia
1235: Venom therapeutics – Chair Dr Eddie Rowan
1240: Dr Igor Krizaj, Professor of Biochemistry, Scientific Counsellor, Group Leader and Head, Department of Molecular and Biomedical Sciences, Jozef Stefan Institute, Ljubljana, Slovenia
New viper venom proteins with high therapeutic potential for blood and cardiovascular disorders
1300: Professor Gisele Picolo, Scientific Researcher, Group Leader, Laboratory of Pain and Signaling, Butantan Institute, São Paulo, Brazil
Potential use of compounds isolated from rattlesnake venom as central modulators of pain and inflammation
1320: Early Career Researchers Latin America
Coordinator: Dr Rita de Cássia Collaço
1325: Miss Vanessa Costa de Oliveira, Universidad de Buenos Aires, Argentina
Antineurotoxic arachnidic polyvalent antivenom experimental production in Argentina
1335: Miss Luz E. Romero, University of Antioquia, Colombia
Recombinant immunogens type phospholipase A2 and three-finger toxin for the production of antivenoms of clinical interest in Colombia
1345: Mr Andrés Agurto, Universidad Nacional Mayor de San Marcos, Peru
Design of primers for the identification of some poisonous Peruvian snakes by the multiplex loop-mediated isothermal amplification reaction
1355: Dr Karen Sarmiento, Pontificia Universidad Javeriana, Colombia
Comparison of the specificity and neutralizing capacity of two antivenoms for snakebite challenged with Bothrops rhombeatus venom
1405: Dr Caroline B F Mourão, University of Brasília (UNB), Brazil
ToPI1, from Tityus obscurus scorpion venom, and its head-to-tail cyclization after interaction with trypsin
1415: Dr Manoela Torres-Rêgo, Federal University of Rio Grande do Norte, Brazil
Biodegradable cross-linked chitosan nanoparticles improve anti-Candida and anti-biofilm activity of TistH, a peptide identified in the venom gland of the Tityus stigmurus scorpion
1425: Recovery from envenoming and treatment – Chair Professor David Warrell
1430: Dr Naira Ayvazyan, Orbeli Institute of Physiology of the National Academy of Sciences, Yerevan, Armenia
Pros and cons of paraspecificity and cross-reactivity of different monospecific anti-Vipera antivenom products towards the Middle East vipers’ venoms
1450: Professor Cesare Montecucco (and Mr Marco Stazi), Emeritus Professor of Neurosciences, CNR Neuroscience Institute, Emeritus Professor of General Pathology, Department of Biomedical Sciences, University of Padova, Padova – Italy
NUCC-39 activates the CXCR4 receptor and accelerates the recovery from the peripheral neuroparalysis induced by Taipan snake envenomation
1510: Professor Andreas Laustsen, Associate Professor, Department of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark
Progress towards next-generation antivenoms
1530: Professor José María Gutiérrez, Instituto Clodomiro Picado, Universidad de Costa Rica, San Jose, Costa Rica
Why is skeletal muscle regeneration impaired after necrosis induced by viperid snake venoms?
1550: Presentation of Lifetime Achievement Award to Dr Charlotte L Ownby, Professor Emeritus, Physiological Sciences, OSU Director Emeritus, OSU Microscopy Laboratory Stillwater, OK, USA (citation by Professor José-María Gutiérrez)
1610: Close of Day 1
Day 2: Thursday 17th September
(Subject to change)
All times mentioned refer to British Standard/Summer Time (BST) – London/GMT +1.
World Time Converter: https://www.worldtimebuddy.com
We have tried to group similar talks, but due to the wide geographical locations of our speakers, this may not always been possible.
0955: Welcome by Dr Eddie Rowan
1000: Professor Glenn King, Professorial Research Fellow, Institute for Molecular Bioscience, The University of Queensland, Queensland, Australia
A spider-venom peptide for treatment of chronic visceral pain
1020: Toxin Themes from SE Asia – Chair Professor David Warrell
MYANMAR
1025: Professor Yi Yi Khine, Myanmar, Senior Nephrologist and Head of National Snakebite Control Programme, Myanmar
The snakebite control programme in Myanmar
1045: Dr Bethany Moos, General Practitioner, Hedena Health, Oxford National Health Services, UK
A retrospective descriptive study of snakebite patients admitted to Yangon General Hospital in Myanmar, in 2018
THAILAND
1105: Dr Lawan Chanhome, Head of Snake Farm, Queen Saovabha Memorial Institute, The Thai Red Cross Society, Bangkok, Thailand
Updates in Venomous Snakes of Thailand: An Issue of Protobothrops kelomohy venom and its envenomation
MALAYSIA
1125: Dr Michelle Khai Khun Yap, School of Science, Monash University Malaysia, Bandar Sunway, Malaysia
The myth of venom cytotoxin – more than just cytolytic actions
1145: Venomous taxa and venom evolution – Chair Professor Anna Nekaris
1150: Dr Ronald Jenner, Department of Life Sciences, The Natural History Museum, London, UK
Horizontal gene transfer is a key mechanism of centipede venom evolution
1210: Miss Mathilde Wells, University of Mons, Laboratory of Pharmaceutical Analysis, Hainaut, Belgium
Discovery strategies for novel antiplasmodial compounds from the venom of Bufo toads
1230: Mr Agneesh Barua, Okinawa Institute of Science and Technology Graduate University, Okinawa, Japan
Toxin expression in snake venom evolves rapidly with constant shifts in evolutionary rates
1250: Professor Juan Calvete, Laboratorio de Venómica Evolutiva y Traslacional, Instituto de Biomedicina de Valencia, CSIC, Valencia, Spain
What’s in a mass?
1310: Break and Posters-II
Poster flash-talks – Moderator Dr Muhammad Sohail
- Edgar Barajas Ledesma, UK
- Adrijana Leonardi, Slovenia
- Yadana Oo, Myanmar
- Enos Emanuel Azevedo Rocha, Brazil
Breakout Rooms
1345: Toxin Themes from the Western hemisphere – Chair Professor José María Gutiérrez
1350: Professor Denise Tambourgi, Principal Investigator and Lead Researcher, Laboratório de Imunoquímica, Instituto Butantan, Brazil
Complement inhibition: a possible therapeutic strategy for controlling cobra envenomation
1410: Professor Elda Sánchez, Director, National Natural Toxins Research Center, Texas A&M University-Kingsville, TX, USA
Paraspecific neutralization of venoms
1430: Professor Fan Hui Wen, Project Manager, Strategic Nucleus for Poison and Antivenom (NEVAS), Instituto Butantan, São Paulo, Brazil
Revisiting the big antivenom crisis in Brazil
1450: Dr Dabor Resiere, Head of Clinical Toxicology Resuscitation Department, Critical Care Unit, University Hospital of Martinique, Fort-de-France, Martinique
Management of severe Bothrops Spp Snakebite Envenomings in French Overseas Departments of the Americas
1510: Poster Prizes – announcement
1530: Discussion and close
